Comparing anesthesia types during bladder cancer surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two types of anesthesia given during bladder cancer surgery to see if one offers better long-term outcomes. You may be eligible if you have early-stage bladder cancer and are having a tumor removal procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 or older (or a woman who has gone through menopause)
- You are physically able to carry on daily activities (fully active to light work)
- You have been diagnosed with or are suspected to have bladder cancer that hasn't spread into the deep muscle wall
- Your kidney and liver function tests are within normal limits
- You haven't had previous bladder cancer in the kidneys, ureters, or urethra
- You are not currently taking long-term anti-inflammatory drugs or beta-blockers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of anesthesia—spinal (numbing the lower body) versus general (putting you to sleep)—for men having prostate surgery to treat benign enlargement. The goal is to see which approach works better and is safer for this procedure.
This study compares two standard treatments for high-grade non-muscle-invasive bladder cancer that has come back after initial treatment: medication placed directly into the bladder (intravesical therapy) or bladder removal surgery (cystectomy). The goal is to see which option works better for patients like you.
This study compares two types of spinal anesthesia (numbing medicine injected near the spine) to see which one works better for patients having TURP, a common prostate surgery. You might benefit from joining because it could help improve your recovery and comfort during the procedure.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
This study tests a new medicine called Alpha1H that is given before the usual surgery to remove bladder cancer. It may help lower the risk of the cancer coming back.
This study tests a new way to give a chemotherapy drug during bladder surgery to help stop the cancer from returning. It is for people with a type of bladder cancer that has not spread into the muscle.
Hear when a new NMIBC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.